Stanford Peng
2019
In 2019, Stanford Peng earned a total compensation of $970.6K as President and Head of Research and Development at Nivalis Therapeutics, a 52% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $208,126 |
|---|---|
| Option Awards | $319,757 |
| Salary | $442,708 |
| Total | $970,591 |
Peng received $442.7K in salary, accounting for 46% of the total pay in 2019.
Peng also received $208.1K in non-equity incentive plan and $319.8K in option awards.
Rankings
In 2019, Stanford Peng's compensation ranked 9,402nd out of 13,971 executives tracked by ExecPay. In other words, Peng earned more than 32.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,402 out of 13,971 | 33rd |
Division Manufacturing | 3,775 out of 5,701 | 34th |
Major group Chemicals And Allied Products | 1,434 out of 2,200 | 35th |
Industry group Drugs | 1,223 out of 1,886 | 35th |
Industry Pharmaceutical Preparations | 910 out of 1,398 | 35th |
Source: SEC filing on May 5, 2020.
Peng's colleagues
We found two more compensation records of executives who worked with Stanford Peng at Nivalis Therapeutics in 2019.